This trial will help researchers learn if PET-MR using PyL is accurate in diagnosing prostate cancer and finding out how far the cancer has spread.
1 Primary · 0 Secondary · Reporting Duration: 5 years
Experimental Treatment
48 Total Participants · 1 Treatment Group
Primary Treatment: 18F-DCFPyL · No Placebo Group · Phase < 1
Age 18 - 89 · Male Participants · 6 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: